The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation by Chen, Jian Fu et al.
The role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation
Jian-Fu Chen1,2, Elizabeth M Mandel1,3, J Michael Thomson2, Qiulian Wu1,2, Thomas E
Callis1,2, Scott M Hammond2, Frank L Conlon1,3,4, and Da-Zhi Wang1,2
1 Carolina Cardiovascular Biology Center,
2 Department of Cell and Developmental Biology,
3 Department of Biology and
4 Department of Genetics, University of North Carolina Chapel Hill, North Carolina 27599, USA.
Abstract
Understanding the molecular mechanisms that regulate cellular proliferation and differentiation is a
central theme of developmental biology. MicroRNAs (miRNAs) are a class of regulatory RNAs of
~22 nucleotides that post-transcriptionally regulate gene expression1,2. Increasing evidence points
to the potential role of miRNAs in various biological processes3–8. Here we show that miRNA-1
(miR-1) and miRNA-133 (miR-133), which are clustered on the same chromosomal loci, are
transcribed together in a tissue-specific manner during development. miR-1 and miR-133 have
distinct roles in modulating skeletal muscle proliferation and differentiation in cultured myoblasts
in vitro and in Xenopus laevis embryos in vivo. miR-1 promotes myogenesis by targeting histone
deacetylase 4 (HDAC4), a transcriptional repressor of muscle gene expression. By contrast, miR-133
enhances myoblast proliferation by repressing serum response factor (SRF). Our results show that
two mature miRNAs, derived from the same miRNA polycistron and transcribed together, can carry
out distinct biological functions. Together, our studies suggest a molecular mechanism in which
miRNAs participate in transcriptional circuits that control skeletal muscle gene expression and
embryonic development.
To understand the potential involvement of miRNAs in skeletal muscle proliferation and
differentiation, we analyzed the expression of miRNAs during skeletal muscle differentiation
using an established microarray analysis9. We used C2C12 myoblasts because these cells
faithfully mimic skeletal muscle differentiation in vitro, as shown by their induction to
terminally differentiated myotubes when serum is withdrawn from the culture medium10–
12. We found that the expression of a few of the miRNAs examined was upregulated in
differentiated C2C12 myoblasts or myotubes (Fig. 1a and Supplementary Fig. 1 online). This
increase in expression of miR-1 and miR-133 in differentiated myoblasts was confirmed by
RNA blot analysis (Fig. 1b and Supplementary Fig. 2 online).
miR-1 and miR-133 are specifically expressed in adult cardiac and skeletal muscle tissues, but
not in other tissues tested13–15 (Fig. 1c and Supplementary Fig. 3 online). Little is known,
however, about the spatio-temporal distribution of specific miRNAs during mammalian
development. We therefore examined the expression of miR-1 and miR-133 in mouse embryos
and neonates. miR-1 and miR-133 are expressed in very small amounts in the developing hearts
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and skeletal muscle of embryonic day 13.5 (E13.5) and E16.5 mice (Fig. 1d and
Supplementary Fig. 3). Increasing expression of miR-1 and miR-133 was found in neonatal
hearts and skeletal muscle, although it was still substantially lower than that in adult tissues
(Fig. 1e and Supplementary Fig. 3). These data are consistent with findings in zebrafish
showing that most miRNAs are expressed relatively late during embryogenesis16.
miR-1 and miR-133 are clustered together both on mouse chromosome 2, where they are
separated by 9.3 kb, and on mouse chromosome 18, where they are separated by 2.5 kb
(Supplementary Fig. 4 online and ref. 14). We carried out northern blot analysis using
genomic probes of ~300 bp including the miR-1 or miR-133 sequence (Supplementary Fig.
4). The probes for miR-1 and miR-133 on chromosome 18 detected a single primary transcript
of ~6 kb in total RNAs isolated from heart and skeletal muscle (Supplementary Fig. 4),
indicating that miR-1 and miR-133 are indeed transcribed together. Whereas the probes for
miR-1 and miR-133 on chromosome 2 both detected a transcript of ~10 kb in the heart and
skeletal muscle, the miR-133 probe hybridized to two additional transcripts of ~4.5 kb and
~2.2 kb, and the miR-1 probe detected an additional major transcript of ~6 kb (Supplementary
Fig. 4), suggesting that post-transcriptional processing may be involved in the production of
miR-1 and miR-133. Together, our data indicate that cardiac-specific and skeletal muscle–
specific expression of miR-1 and miR-133 is dictated at the primary transcription step.
We reasoned that the regulatory elements that control the transcription of both the chromosome
2 and the chromosome 18 miR-1 and miR-133 clusters are probably conserved. We therefore
used sequence analysis to identify a highly conserved region (~2 kb) that lies about 50 kb
upstream of the miR-1–miR-133 clusters on both chromosome 2 and chromosome 18
(Supplementary Fig. 5 online). When this genomic fragment from chromosome 2 was used
to drive the expression of a dsRed reporter gene in transgenic X. laevis, we found cardiac-
specific and skeletal muscle–specific expression of the transgene (Supplementary Fig. 5).
To assess the function of miR-1 and miR-133 in skeletal muscle, we first attempted to
overexpress miR-1 and miR-133 in mammalian cells. We tested and validated the expression
and activity of both miRNAs by RNA blot analysis, as well as by using miR-1 and miR-133
‘sensors’17, in which the complementary sequences of miR-1 and miR-133 are cloned
downstream of a dsRed coding sequence (Supplementary Fig. 6 online and data not shown).
We transfected C2C12 myoblasts with miR-1 or miR-133 and then either maintained cells in
growth medium or transferred them to differentiation medium after transfection. miR-1
strongly enhanced myogenesis, as indicated by an increase in expression of the respective early
and late myogenic markers myogenin and myosin heavy chain (MHC), as well as other
myogenic markers including MyoD, MEF2 and skeletal α-actin (Fig. 2 and Table 1). miR-1
induced the expression of myogenic marker genes in cells maintained in the log-phase growth
condition (Fig. 2c) and in the differentiation condition (Fig. 2d,e).
Accelerated myogenic differentiation induced by miR-1 was accompanied by a decrease in
cell proliferation, as marked by a significant decrease in expression of phosphorylated histone
H3 (phospho–histone H3; Fig. 2c,e and Table 1). We found that miR-1-induced myogenesis
is specific, because overexpression of a green fluorescent protein control RNA duplex (miGFP)
or miR-208, which is not endogenously expressed in skeletal muscle cells, showed no effect
(Fig. 2a–e). In addition, mutations introduced into miR-1 ‘seed’ sequences abolished its ability
to activate myogenic gene expression (Fig. 2d,e). By contrast, overexpression of miR-133
repressed the expression of myogenin and MHC (Fig. 2a–e and Table 1) and promoted
myoblast proliferation (Fig. 2c,e and Table 1). Again, we found that the effect of miR-133 on
myoblasts proliferation is specific, because controls showed no effect and the mutation
introduced abolished the function of miR-133 (Fig. 2a–e,j).
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We carried out a reciprocal experiment wherein we transfected C2C12 myoblasts with 2′-O-
methyl antisense inhibitory oligoribonucleotides, which have been shown to inhibit the
function of miRNAs18,19, targeted towards miR-1 or miR-133 (or control miGFP and
miR-208). Cells transfected with the miR-1 inhibitor showed inhibition of myogenesis and
promotion of myoblast proliferation, as indicated by a decrease in myogenic markers and an
increase in phospho–histone H3 (Fig. 2f–i and Table 1). Consistent with the role of miR-133
in promoting myoblast proliferation and repressing differentiation, inhibition of miR-133
caused an opposing effect, whereby myogenesis was enhanced and cell proliferation was
repressed (Fig. 2f–j and Table 1). By contrast, the control 2′-O-methyl inhibitors showed no
effects (Fig. 2f–j). We conclude that miR-1 and miR-133 have distinct roles in skeletal muscle
proliferation and differentiation: miR-1 promotes myoblast differentiation, whereas miR-133
stimulates myoblast proliferation.
Both miR-1 and miR-133 have been found in most animal species, from Drosophila to human,
suggesting that they are evolutionary conserved. To test the effects of miR-1 and miR-133 on
skeletal muscle and heart development in vivo, we identified copies of miR-1 and miR-133 in
X. laevis and tested their function through misexpression. Introduction of miR-1 at the one-
cell stage led to a markedly shortened axis with an accompanying reduction in anterior
structures and an increase in body size along the dorsal-ventral axis, as compared with either
uninjected or miGFP-injected controls (n > 50, two independent experiments; Fig. 3). Although
somites formed in embryos injected with miR-1 (Fig. 3), whole-mount antibody staining and
serial sectioning showed that the tissue was highly disorganized and did not develop into
segmented structures (Fig. 3e,f,j). Cardiac tissue was completely absent, as judged by
histology, staining for tropomyosin (Fig. 3f,j) and staining for cardiac actin (data not shown).
In addition to these defects, there was a marked decrease in phospho–histone H3 staining (Fig.
3i–k), consistent with the notion that miR-1 is essential in regulating muscle cell proliferation
and differentiation.
Misexpression of miR-133 also led to a reduction in anterior structures and defects in somite
development but, in contrast to misexpression of miR-1, there was only a modest reduction in
anterior-posterior length and somitic defects were most severe in the more anterior or posterior
aspects of the embryo where somites failed to form (Fig. 3g,h). In addition, cardiac tissue
frequently formed in miR-133-injected embryos, although it was highly disorganized and did
not undergo cardiac looping or chamber formation (Fig. 3g,h,k and data not shown).
Collectively, these data suggest that correct temporal expression and amounts of both miR-1
and miR-133 are required for proper skeletal muscle and heart development.
To identify target genes that might mediate the observed effects of miR-1 and miR-133 on
skeletal muscle proliferation and differentiation, we next examined potential targets of these
two miRNAs. Many computational and/or bioinformatics-based approaches have been used
to predict numerous potential targets of miRNAs20–22. Strikingly, many transcription factors
have been suggested to be targets of miRNAs, raising the possibility that miRNAs might be
involved in transcriptional regulation of gene expression. Among the predicted targets of
miR-1, HDAC4 has been shown to inhibit muscle differentiation and skeletal muscle gene
expression, mainly by repressing MEF2C, an essential muscle-related transcription factor12,
23. HDAC4 contains two naturally occurring putative miR-1-binding sites at its 3′ UTR, which
are evolutionarily conserved among vertebrate species (Supplementary Fig. 7 online).
Similarly, two conserved miR-133-binding sites are found in the 3′ UTR of the mammalian
gene encoding SRF (Supplementary Fig. 7), which has been shown to be important in muscle
proliferation and differentiation in vitro and in vivo11,24,25.
We fused the 3′ UTRs of mouse SRF and HDAC4 to a luciferase reporter gene and transfected
these constructs, along with transfection controls, into mammalian cells. Ectopic
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overexpression of miR-1 strongly repressed the HDAC4 3′ UTR luciferase reporter gene,
whereas over-expression of miR-133 inhibited the SRF 3′ UTR luciferase reporter gene (Fig.
4a). By contrast, mutations introduced into miR-1 or miR-133 seed sequences abolished this
repression, indicating the specificity of the action (Fig. 4a).
When the above reporters were transfected into C2C12 myoblasts and luciferase activity was
measured before and after the induction of cell differentiation, reporter gene activity was
markedly repressed in differentiated cells (Fig. 4b), indicating that the increase in endogenous
miR-1 and miR-133 inhibited the reporter gene. The effects and specificity of endogenous
miR-1 and miR-133 were monitored by the miRNA sensor (Supplementary Fig. 6). By
contrast, the activity of a luciferase reporter gene for MCK, an indicator of muscle
differentiation, was increased in differentiated muscle cells (Fig. 4b). In addition,
overexpression of miR-1 led to the downregulation of endogenous HDAC4 protein in C2C12
cells in both the growth condition (Fig. 4c) and the differentiation condition (Fig. 4e), whereas
overexpression of miR-133 repressed the expression of endogenous SRF proteins (Fig. 4c,e).
By contrast, the mRNA levels of SRF and HDAC4 were not altered by these miRNAs (Fig.
4d), supporting the notion that miRNAs repress the function of their target genes mainly by
inhibiting translation. The application of 2′-O-methyl-antisense oligoribonucleotides targeted
towards miR-1 or miR-133 relieved the repression of HDAC4 or SRF protein, respectively
(Fig. 4g), but had no effect on their mRNA levels (Fig. 4f).
To verify that HDAC4 and SRF are cognate targets of miR-1 and miR-133 in regulating skeletal
muscle gene expression, we tested whether cotransfecting expression plasmids encoding SRF
and HDAC4 could ‘suppress’ miRNA-mediated myogenesis. Indeed, over-expression of SRF
partially reversed the myogenic gene repression induced by miR-133 (Fig. 4h), whereas
overexpression of HDAC4 counteracted the effects of miR-1 on skeletal muscle gene
expression (Fig. 4h). Consistent with the potential involvement of HDAC4 and SRF in miR-1-
and miR-133-dependent skeletal muscle proliferation and differentiation, endogenous HDAC4
and SRF protein was down-regulated in differentiated C2C12 cells, coupled with a concomitant
increase in expression of myogenic differentiation markers and a decrease in expression of the
mitotic index marker phospho–histone H3 (Fig. 4i and Supplementary Fig. 2 online). The
decrease in expression of SRF and HDAC4 protein was accompanied by an increase in
expression of miR-1 and miR-133 (compare Fig. 4i with Fig. 1b). Together, these data show
that miR-1 and miR-133 specifically repress HDAC4 and SRF protein, respectively, which in
turn contributes to (at least in part) the regulatory effects of these miRNAs on myoblast
proliferation and differentiation.
In summary, we have characterized cardiac-specific and skeletal muscle–specific miR-1 and
miR-133 and have shown their essential functions in controlling skeletal muscle proliferation
and differentiation. Notably, we have shown that miR-1 and miR-133, which are clustered on
the same chromosomal loci and transcribed together as a single transcript, become two
independent, mature miRNAs with distinct biological functions achieved by inhibiting
different target genes. This finding implicates miRNAs in complex molecular mechanisms.
Although the tissue-specific expression of miR-1 and miR-133 is controlled by MyoD and
SRF8, expression of SRF is repressed by miR-133. Thus, these findings identify a negative
regulatory loop in which miRNAs participate to control cellular proliferation and
differentiation (Fig. 5). In the future, it will be interesting to determine whether miR-1 and
miR-133 are involved in cardiac-related and skeletal muscle–related human diseases.
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Analysis of microRNA expression by microarray
Total RNA was isolated from C2C12 cells cultured in growth medium comprising DMEM
(Sigma) plus 10% fetal bovine serum (Sigma) and 1% penicillin or streptomycin (Invitrogen)
or differentiation medium comprising DMEM (Sigma) plus 2% horse serum (Sigma) at
different time points (days 0, 1, 3 and 5, where day 0 was the first day after transfer into
differentiation medium). Microarray hybridization and data analysis were done as
described9. In brief, 2.5 μg of isolated RNA was labeled with 5′-phosphate-cytidyl-uridyl-
Cy3-3′ (Dharmacon) using RNA ligase and hybridized with a 0.5-mM mixture of
oligoribonucleotide probes for 124 miRNAs labeled with Alexa 647 (Cy5) in SLF-0601
disposable chambers (MJ Research). Normalized log2 data were hierarchically clustered by
gene and plotted as a heat map.
Northern blot analysis
Total RNA was extracted from C2C12 cells, mouse embryonic tissue or adult tissue with Trizol
Reagent (Invitrogen). To aid analysis of miRNA, polyethylene glycol (PEG) was applied to
remove large-sized RNAs. In brief, 30 μg of each total RNA sample was mixed 1:1 with 5×
PEG solution and placed on ice for 10 min. After 10 min of centrifugation at maximum speed
at 4 °C, the supernatant was transferred to a fresh tube. RNAs were then precipitated by adding
2.5 volumes of 100% ethanol, followed by centrifugation for 30 min at maximum speed.
Northern blot analysis of miRNAs was done as described13. The miR-1 and miR-133
oligonucleotide sequences used as probes are listed in Supplementary Table 1 online.
Northern blot analysis to detect primary transcripts of miRNAs was done as described26 using
20 μg of total RNA from each sample. Genomic fragments of miR-1 and miR-133 were cloned
by PCR and used as probes.
Cloning and expression of miR-1 and miR-133
Genomic fragments of miR-1 and miR-133 precursors from mouse chromosomes 2 and 18
were amplified by PCR using mouse genomic DNA as a template (for PCR primers, see
Supplementary Table 1). The PCR products were cloned into the pDNA(+)3.1 vector
(Invitrogen) and miRNA expression was detected by RNA blot analysis after transfecting the
expression vectors into mammalian cells (COS7, 10T1/2 or C2C12).
Cell culture, in vitro myogenesis differentiation and luciferase reporter assay
C2C12 myoblast cells were cultured and myogenesis was induced as described12. Transient
transfection luciferase reporter assays were done as described12,26. miRNA duplexes and 2′-
O-methyl antisense oligoribo-nucleotides targeted towards miR-1, miR-133, miR-208 and
miGFP were purchased from Dharmacon (see Supplementary Table 1 for sequences) and
introduced into mammalian cells by either Lipofectamine (Invitrogen) transfection (200 nM)
or electroporation with the Nucleofector (Amaxa) system (5 μg).
For construction of the 3′-UTR-luciferase reporter, the multiple cloning site of the pGL3-
Control vector (Promega) was removed and placed downstream of the luciferase gene. We
amplified the 3′ UTRs of mouse HDAC4 and SRF by PCR and cloned them into the modified
pGL3-Control vector, resulting in the constructs SRF-3′-UTR and HDAC4-3′-UTR (see
Supplementary Table 1 for PCR primer sequences). Luciferase reporter assays were done as
described26.
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Immunoblotting was done as described27 using antibodies to myogenin, SRF, MEF2, HDAC4
and β-tubulin (Santa Cruz Biotechnology), and to phospho–histone H3 (Upstate
Biotechnology). The MF20 antibody, which recognizes striated muscle-specific MHC, was
obtained from the DSHB (University of Iowa). For immunostaining, C2C12 cells treated in
12-well plates were fixed with 4% formaldehyde for 5 min at 37 °C and washed in 0.1% Nonidet
P40 (NP40) in PBS for 15 min at room temperature. Primary antibodies were incubated in
0.1% NP40 in PBS plus 3% bovine serum albumin (BSA) for 2 h in the following
concentrations: anti-myogenin, 1:20 dilution; anti–phospho–histone H3, 1:100 dilution; MF20,
1:10 dilution. The secondary antibodies, fluorescein-conjugated anti-mouse and anti-rabbit
(1:100 dilution, Vector Laboratories), were added in 0.1% NP40 plus 3% BSA in PBS for 1 h
at 37 °C. 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) was then added for 5 min at
room temperature. After several washes with PBS, cells were subjected to fluorescence
microscopy. For each well, ten fields covering the whole well were picked and green
fluorescence–positive cells and total cells with DAPI staining were counted.
RT-PCR analysis
RT-PCR was done essentially as described27. Total RNA was extracted from C2C12 cells
with Trizol Reagent (Invitrogen), and 2.0-μg samples were reverse-transcribed to cDNA by
using random hexamers and MMLV reverse transcriptase (Invitrogen). In each analysis, 2.5%
of the cDNA pool was used for amplification and PCR was done for 24–28 cycles. The
sequences of the PCR primers are given in Supplementary Table 1.
X. laevis embryo injections and transgenesis
Standard methods were used to obtain and culture X. laevis embryos. DNA constructs were
linearized with KpnI and transgenic embryos were generated as described28. Expression of
the transgene was analyzed under an MZFLIII microscope (Leica). Preparation and injection
of X. laevis with miRNAs was done essentially as described29, except that RNA was not capped
before injection. Whole-mount immunohistological analysis was done as described30.
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Expression of miR-1 and miR-133 in cardiac and skeletal muscle during development. (a)
miRNA array expression data from C2C12 myoblasts cultured in growth medium (GM) or in
differentiation medium (DM) for 0, 1, 3 or 5 d. Normalized log2 data were hierarchically
clustered by gene and are plotted as a heat map. The signal ranged from a fourfold decrease to
a fourfold increase. Yellow denotes high expression and blue denotes low expression relative
to the median; only the miRNA nodes that were upregulated in differentiation medium are
shown. (b) Northern blot analysis of miR-1 and miR-133 expression using total RNA isolated
from C2C12 myoblasts cultured in growth medium or in differentiation medium DM for 0, 1,
3 or 5 d. tRNAs were used as a loading control. (c) Northern blot analysis of miR-1 and miR-133
expression in adult mouse tissues. (d) Northern blot analysis of miR-1 and miR-133 expression
in E13.5 and E16.5 mouse tissues. (e) Northern blot analysis of miR-1 and miR-133 expression
in neonatal mouse tissues. The same amount of total RNAs from adult heart and skeletal muscle
was loaded on the blots to compare embryonic and neonate RNA (d,e).
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Regulation of myoblast proliferation and differentiation by miR-1 and miR-133. C2C12
myoblasts cultured in growth medium were electroporated with double-stranded miR-1,
miR-133 or control miGFP. (a,b) Cells were continuously cultured in growth medium for 24
h after transfection and then transferred to differentiation medium for either 12 h before
immunostaining for myogenin (a) or 36 h before immunostaining for MHC (b). (c–e) C2C12
myoblasts cultured in GM were electroporated with double-stranded miR-1, miR-133 (or their
mutants as indicated) or control miR-208 or miGFP and cultured for 24 h before being either
subjected to immunoblotting with the indicated antibodies (c), or transferred to differentiation
medium for 24 h and subjected to RT-PCR for the indicated genes (d) or to immunoblotting
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with the indicated antibodies (e). (f–h) C2C12 myoblasts cultured in GM were electroporated
with a 2′-O-Methyl antisense oligonucleotide inhibitors of miR-1, miR-133, miR-208 or
miGFP as controls. Cells were cultured in growth medium for 24 h after transfection and then
transferred into differentiation medium for 12 h before immunostaining for phospho–histone
H3 (f), 24 h before RT-PCR for the indicated genes (g) or 24 h before immunoblotting with
the indicated antibodies (h). (i,j) C2C12 myoblasts cultured in growth medium were
electroporated with miRNA duplexes or with 2′-O-Methyl antisense oligonucleotide inhibitors
as indicated. Cells were cultured in growth medium for 24 h after transfection and then
transferred into DM for 12 h before immunostaining for myogenin (i) or phospho–histone H3
(j). Positive stained cells were counted and data are presented as the expression level relative
to a miGFP control (100%).
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Control of cardiac and skeletal muscle development by miR-1 and miR-133 in vivo. (a–h)
Images of uninjected (a,b), control miGFP-injected (c,d), miR-1-injected (e,f) and miR-133-
injected (g,h) X. laevis embryos stained with anti-tropomyosin and shown at stage 32 under
bright-field (a,c,e,g) or fluorescence (b,d,f,h) microscopy. Note the lack of staining for heart
tissue (H, arrows) and the disruption of segmented somites (S, arrows) in f and h. (i–k)
Transverse sections corresponding to the position of the heart at stage 32 in uninjected (i),
miR-1-injected (j) and miR-133-injected (k) X. laevis embryos stained with anti-tropomyosin
to visualize somites (S, arrows) and cardiac tissue (H, arrows), and antibody to phospho–
histone H3 (red) to visualize cells in S phase. Each set of injections was conducted at least
twice independently, and the phenotype was observed in at least 90% of a minimum of 50
embryos scored by whole-mount immunostaining.
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Identification of miR-1 and miR-133 target genes in skeletal muscle. (a) Repression of SRF
and HDAC4 3′ UTRs by miR-133 and miR-1. Luciferase reporters containing either miR-133
complementary sites from mouse SRF 3′ UTR (SRF-3′-UTR), miR-1 complementary sites
from mouse HDAC4 3′ UTR (HDAC4-3′-UTR) or the perfect antisense sequences of miR-133
(miR-133-luc) or miR-1 (miR-1-luc) were cotransfected with the indicated miRNA expression
vectors. Luciferase activity was determined 48 h after transfection. Data represent the mean ±
s.d. from at least three independent experiments done in duplicate (*P < 0.05). (b) SRF-3′-
UTR, HDAC4-3′-UTR and MCK-luc luciferase reporters were transfected into C2C12
myoblasts. Cells were maintained in growth medium for 24 h (GM) or transferred into
differentiation medium for 1 d (DM1) or 3 d (DM3) before luciferase activity was determined.
(c–e) C2C12 myoblasts cultured in growth medium were electroporated with the indicated
miRNA duplexes (or their mutants), or miR-208 and miGFP as controls. Cells were cultured
in growth medium for 24 h after transfection before being either subjected to immunoblotting
with anti-SRF and anti-HDAC4 antibodies (c), or transferred into differentiation medium for
24 h and subjected to RT-PCR for the indicated genes (d) or to immunoblotting with the
indicated antibodies (e). (f,g) C2C12 myoblasts cultured in growth medium were
electroporated with the indicated 2′-O-Methyl antisense oligonucleotide inhibitors. Cells were
cultured in growth medium for 24 h after transfection and transferred into differentiation
medium for 24 h before being subjected to RT-PCR for the indicated genes (f) or to
immunoblotting with indicated antibodies (g). (h) C2C12 myoblasts cultured in growth
medium were electroporated with the indicated miRNA duplexes and/or expression plasmids
for SRF or HDAC4, as indicated. Cells were cultured in growth medium for 24 h after
transfection. Immunoblotting with the indicated antibodies was done 24 h after transfer into
differentiation medium. (i) C2C12 myoblasts were cultured in growth medium or
differentiation medium for 0, 1, 3 or 5 d and subjected to immunoblotting with the indicated
antibodies.
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Model of miR-1 and miR-133-mediated regulation of skeletal muscle proliferation and
differentiation. Tissue-specific expression of miR-1 and miR-133 clusters is regulated by SRF
and myogenic transcription factor MyoD. miR-1 and miR-133 modulate muscle proliferation
and differentiation, in part, by targeting HDAC4 and SRF, respectively.
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